EUVIMEDDescoperă EUVIMED
EUVIMED · CrossrefJournal

Journal of Medicinal Chemistry

ISSN 0022-2623 · American Chemical Society (ACS)

Latest articles

  1. Discovery of Pan-KRAS Inhibitor GNE-6226: Harnessing an Aminopyridine Pharmacophore to Broadly Target KRAS Mutants

    Benjamin D. Ravetz, Mark Merchant, BinQing Wei, Elizabeth H. Kelley, Maureen H. Beresini, Kamakoti P. Bhat, Jingwei Cai, Xiaodan Chang, Stefan Chun, Stephanie Dale, Cecile C. de la Cruz, Darlene Dela Cruz, F. Esra Demircioglu, Lin Deng, Lewis Gazzard, Luca Gerosa, Thomas L. Hunsaker, Matthew L. Landry, Kaylee Lee, Eva Lin, Aijun Lu, Fang Ma, Sushant Malhotra, Jeremy M. Murray, Lionel Rouge, Matthew J. Saabye, Pablo Saenz-Lopez Larrocha, Ehud Segal, Cheng Shao, Yinlei Sun, Weiru Wang, Guosheng Wu, Xin Ye, Yulai Zhang, Jun Zou, Marie Evangelista, Jack A. Terrett

    Published: 2026-11-21DOI: 10.1021/acs.jmedchem.6c02035

  2. Discovery and Clinical Development of Ceperognastat, a Low-Dose, CNS-Penetrant O -Linked N -Acetylglucosaminidase Inhibitor

    Hugh N. Nuthall, William Kielbasa, Eric M. Woerly, Jorg Hendle, Paul Goldsmith, Susan L. Dubois, Feiyu Fred Zhang, Kevin B. Donnelly, Adam S. Fleisher, Stephen L. Lowe, Sergey Shcherbinin, Leonard L. Winneroski, Jose E. Lopez, Nicolas J.-F. Dreyfus, David A. Evans, Peter J. Lindsay-Scott, Richard E. Rathmell, Jeremy Gilmore, Emily C. Collins, Michele Mancini, Michael Hutton, Dustin J. Mergott

    Published: 2026-11-21DOI: 10.1021/acs.jmedchem.6c02053

  3. Correction to Discovery of DT-9081, a Potent and Orally Bioavailable Small Molecule Antagonist of the EP4 Receptor for the Treatment of Solid Cancers

    Anne-Laure Blayo, Gaël Hommet, Mickaël Fer, Célia Halter, Camille Amalric, Philippe Cluzeau, Gaële Fraboulet, Sitty Mikidadi, Noémie Lotz, Sébastien Tarlet, Ludovic Herbin, Baptiste Manteau, Malaury Schappler, Laurène Deshons, Alexia Dumont, Luc Baron, Edith Steinberg, Camille Dietsch, Lola Lecru, Thomas Maurin, Orphée Blanchard, Christel Franchet, Ismet Dorange, Stanislas Mayer, Stephan Schann

    Published: 2026-11-20DOI: 10.1021/acs.jmedchem.6c03329

  4. Development of Second Generation Thieno[2,3- d ]pyrimidin-4-one Derivatives as Positive Allosteric Modulators of the N -Methyl- d -Aspartate Receptor

    Nicholas S. Akins, Paul J. Arcoria, Hyungyu Lee, Srinu Paladugu, Russell G. Fritzemeier, Kyler W. Pugh, Maia Cirvello, Paul J. Tholath, Elijah Z. Ullman, Rehan Sheikh, Kelsey A. Nocilla, Scott J. Myers, Leah McCarthy, Andrew A. Shirley, Manohar T. Saindane, Alet E. van der Westhuyzen, Ken Liu, Yanli Yang, Samantha Burton, Manisha Sharma, Michael P. D’Erasmo, Ryan Keable, Miguel A. Yague, Jamie Maguire, Matthew J. Kennedy, Stephen F. Traynelis, Dennis C. Liotta

    Published: 2026-11-19DOI: 10.1021/acs.jmedchem.6c01874

Volumes

2026 · 1,5092025 · 1,5672024 · 1,2862023 · 1,0292022 · 9752021 · 1,0682020 · 9732019 · 7722018 · 7972017 · 7562016 · 8372015 · 7592014 · 8362013 · 8232012 · 9252011 · 7412010 · 8182009 · 8712008 · 9272007 · 7672006 · 9242005 · 9322004 · 7812003 · 6502002 · 6662001 · 5332000 · 5761999 · 6081998 · 6341997 · 5721996 · 7371995 · 6211994 · 6121993 · 6031992 · 6851991 · 5211990 · 5331989 · 4361988 · 4141987 · 428

Cunoștințe potrivite muncii dumneavoastră.

De la începutul gratuit și cercetarea bibliografică personală până la Research Suite complet.

Vezi tarifele →

Sunt incluse toate textele integrale ale editorilor?

Nu. Referințele bibliografice, rezumatele și textele integrale sunt conținuturi diferite. Disponibilitatea unui text integral depinde de sursă, de Open Access și de licențele pe care le aveți deja. Un abonament EUVIMED nu înlocuiește drepturile suplimentare ale editorilor.